{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10904165", "DateCompleted": {"Year": "2000", "Month": "09", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "31"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "71", "Issue": "1-2", "PubDate": {"Year": "2000", "Month": "Jul"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Antinociceptive mechanisms of dipsacus saponin C administered intrathecally in mice.", "Pagination": {"StartPage": "211", "EndPage": "218", "MedlinePgn": "211-8"}, "Abstract": {"AbstractText": ["Dipsacus saponin C (DSC) administered intrathecally (i.t.) showed antinociceptive effect in a dose-dependent (from 3.75 to 30 microg) manner as measured by the tail-flick assay. The antinociception induced by DSC at the dose of 30 microg reached at peak 7.5 min and almost returned to the control level after 60 min. 5-Amino-valeric acid (5-AVA, a GABA(A) receptor antagonist, from 1 to 20 microg) and SR 95531 (a GABA(B) receptor antagonist, from 0.1 to 2 ng) dose-dependently attenuated i.t. administered DSC-induced increase of the inhibition of the tail-flick response. The i.t. injection of yohimbine (an alpha(2)-adrenergic receptor antagonist, from 1 to 20 microg) and methysergide (a serotonin receptor antagonist, from 1 to 20 microg), but not naloxone (from 2 to 8 microg), significantly attenuated inhibition of the tail-flick response induced by DSC (30 microg) administered i.t. Sulfated cholecystokinin (CCK, from 0.05 to 0.5 ng) injected i.t. significantly reduced the inhibition of the tail-flick response induced by DSC (30 microg) administered i.t. Our results suggest that DSC shows an antinociceptive effect when it is administered spinally and GABA(A), GABA(B), alpha(2)-adrenergic and serotonin receptors located at the spinal cord level, but not opioid receptors, may be involved in DSC-induced antinociception. Furthermore, CCK may play an important role for the modulation of i. t. injected DSC-induced antinociception."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Institute of Natural Medicine, College of Medicine, Hallym University, 1 Okchun-Dong, Chunchon, 200-702, Korea. hesuh@sun.hallym.ac.kr"}], "Identifier": [], "LastName": "Suh", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Song", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huh", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Son", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Y", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic alpha-Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA-A Receptor Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA-B Receptor Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Adrenergic, alpha-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Cholecystokinin"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Serotonin"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Antagonists"}, {"RegistryNumber": "152406-43-4", "NameOfSubstance": "dipsacus saponin C"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Adrenergic alpha-Antagonists"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "GABA-A Receptor Antagonists"}, {"QualifierName": [], "DescriptorName": "GABA-B Receptor Antagonists"}, {"QualifierName": [], "DescriptorName": "Injections, Spinal"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pain Measurement"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Adrenergic, alpha-2"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Receptors, Cholecystokinin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, GABA"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Serotonin"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serotonin Antagonists"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "7", "Day": "25", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "9", "Day": "23", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "7", "Day": "25", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10904165", "10.1016/s0378-8741(99)00204-4", "S0378874199002044"]}}], "PubmedBookArticle": []}